Form 4 for TMO Thermo Fisher Scientific
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0001127602-22-020757 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-10 | 2022-08-08 | TMO | Boxer Michael A | SVP, GC | S - Sale+OE | $590.80 | -7,283 | 12.4K | -37% | -$4.30M |
| D | 2022-08-10 | 2022-08-08 | TMO | Boxer Michael A | SVP, GC | M - OptEx | $192.98 | +7,283 | 19.7K | +59% | +$1.41M |
| D | 2022-08-10 | 2022-08-08 | TMO | Boxer Michael A | SVP, GC | M - OptEx | $0.00 | -7,283 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-08 | S | D | 7,283 | $590.80 | 12,398 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-08 | M | A | 7,283 | $192.98 | 19,681 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-08-08 | M | D | 7,283 | $0.00 | 0 | D | $192.98 · — to 2025-01-02 | 7,283 Common Stock | (F2) The option vested in four equal installments on January 2, 2019, 2020, 2021, and 2022. |